Methylprednisolone as Adjunct to Endovascular Thrombectomy for Patients With Acute Ischemic Strokes With Large Infarct: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial (MIRACLE)
Methylprednisolone as Adjunct to Endovascular Thrombectomy for Patients With Acute Ischemic Strokes With Large Infarct: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial (MIRACLE)
The efficacy and safety of methylprednisolone in acute ischemic stroke patients with large infarct cores (ASPECTS score < 6 or infarct volume ≥50 mL) due to anterior circulation large vessel occlusion have not been clearly established. This is a multi-center, randomized, double-blind, placebo-controlled trial to investigate early combination therapy with methylprednisolone for reperfusion in acute large core infarction.
Inclusion Criteria:
Exclusion Criteria:
Fuzhou, Fujian 350003, China
Fuzhou, Fujian 350005, China
Quanzhou, Fujian 362000, China
Wuhan, Hubei 430014, China
Wuhan, Hubei 430030, China
Nanchang, Jiangxi 330006, China
Jinan, Shandong 250011, China
Shanghai, Shanghai Municipality 200025, China
Mianyang, Sichuan 621000, China